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ORIGINAL RESEARCH COMMUNICATION
Increased Susceptibility to Metabolic Syndrome
in Adult Offspring of Angiotensin Type 1
Receptor Autoantibody-Positive Rats
Suli Zhang,1,2 Xi Zhang,3 Lihong Yang,1 Zi Yan,1 Li Yan,1 Jue Tian,4 Xiaoyu Li,1 Li Song,3 Li Wang,1
Xiaoli Yang,5 Ronghua Zheng,1 Wayne Bond Lau,6 Xinliang Ma,6 and Huirong Liu1,3,7
Abstract
Aims: Abnormal fetal and early postnatal growth is closely associated with adult-onset metabolic syndrome
(MetS). However, the underlying etiological factors remain complex. The presence of the autoantibody against
the angiotensin II type 1 receptor (AT1-Ab), a known risk factor for pre-eclampsia, may create a suboptimal
intrauterine fetal environment. The current study investigated whether middle-aged offspring of AT1-Ab-
positive mothers were prone to metabolic disorder development. Results: The AT1-Abs was detected in pla-
cental trophoblastic cells, capillary endothelium, and milk of pregnant rats actively immunized with the second
extracellular loop of the AT1 receptor. AT1-Abs in newborn rats induced vasoconstriction, increased intracel-
lular-free Ca2+ in vitro, and was undetectable 7 weeks later. Immunized group offspring exhibited increased
weight variability and insulin resistance at 40 weeks of age under a normal diet, evidenced by elevated fasting
serum insulin and homeostasis model assessment score compared with the vehicle control. To further observe
metabolic alterations, the offspring were given a high-sugar diet (containing 20% sucrose) 40–48 weeks post-
natally. The fasting plasma glucose in immunized group offspring was markedly increased. Concomitantly,
these offspring manifested increased visceral adipose tissue, increased fatty liver, increased triglycerides, de-
creased high-density lipoprotein cholesterol, and decreased adiponectin levels, indicative of MetS. Innovation:
AT1-Abs could be transferred from mother to offspring via the placenta and milk. Moreover, offspring of an
AT1-Ab-positive mother were more vulnerable to MetS development in middle age. Conclusion: AT1-Ab-
positivity of mothers during pregnancy is a previously unrecognized ‘‘silent’’ risk factor for MetS development
in their offspring. Antioxid. Redox Signal. 17, 733–743.
Introduction
With current lifestyle changes and the global epi-demic of obesity, a striking increase in the number of
people with metabolic syndrome (MetS) has taken place
worldwide. The syndrome is considered to be closely related
to a high risk of cardiovascular diseases (CVD) and type 2
diabetes mellitus, which are major causes of morbidity and
mortality in the world (21, 22, 31). To our knowledge, complex
interactions between genes, an atherogenic diet, a sedentary
lifestyle, and environmental factors could lead to MetS.
However, growing evidence has highlighted the fetal origin of
Innovation
The current study demonstrated for the first time that
the autoantibody against the angiotensin II type 1 receptor
(AT1-Abs) (an adverse factor existing in pre-eclamptic
patients as well as in a small number of normotensive
pregnant women) was transferred from mother rats to
their offspring via the placenta/milk and caused insulin
resistance and increased susceptibility to metabolic syn-
drome (MetS), a major risk factor for cardiovascular dis-
ease. These findings identified that AT1-Abs in mothers is a
risk factor that should not be ignored because of the pos-
sibility of the development of MetS in their descendents.
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the adult disease (FOAD) hypothesis, which proposes that
adult-onset MetS and CVD are also closely associated with the
intrauterine and initial extrauterine stages of life. Multiple
insults, including maternal exposure to harmful factors, in-
adequate placental perfusion, and/or poor/excess maternal
nutrition, may result in intrauterine growth restriction
(IUGR), with extenuating consequences on adult health.
However, the etiology and pathogenesis of FOAD are com-
plex and not fully understood at present (15, 20, 28).
Recently, evidence about the autoantibody against the an-
giotensin II type 1 receptor (AT1-Ab), first detected in nearly
all women with severe pre-eclampsia and in a small number
of normotensive pregnant women, might lead to the fact that
IUGR has emerged (12). This autoantibody specifically rec-
ognizes the functional epitope of the second extracellular loop
of the AT1 receptor (amino-acid residues 165–191, AT1R-
ECII), possessing AT1 receptor agonist-like pathological ef-
fects (29). Previous studies demonstrated that AT1-Ab might
cause impaired placental perfusion via varied mechanisms
(30), such as enhancing NADPH-reactive oxygen species
production (4), minimizing trophoblast invasion (32), and
increasing placental cell apoptosis in vitro (12). Interestingly, a
clinical study reported that the AT1-Ab was also detected in
the fetal cord blood of antibody-positive mothers (10). The
onslaughts just mentioned may contribute to pathological
placental injury, limiting intrauterine fetal growth and matu-
ration. However, there is a lack of more direct evidence dem-
onstrating how the antibody affects offspring development.
The potential path by which the maternal AT1-Ab transference
to offspring occurs is unclear. The biological properties of the
AT1-Ab within offspring require further elucidation. Most
importantly, whether the antibodies might exert negative ef-
fects on offspring health in later years is completely unknown.
Therefore, the aims of the current study were to (i) deter-
mine the route(s) of AT1-Ab transference from mother rats to
offspring; (ii) study whether the AT1-Ab present in newborn
rats is biologically active; and (iii) investigate whether such
offspring have increased susceptibility to MetS on maturation.
Results
Successful establishment of AT1-Ab-positive
female rat models by active immunization
Of the 12 actively immunized female rats, 10 generated
increased serum AT1-Ab levels 2 weeks after initial immu-
nization, determined by an enzyme-linked immunosorbent
assay (ELISA). As seen in Figure 1A, the target antibody level
peaked at the 8th week (optical density [OD] value, 2.76 – 0.09
vs. 0.33 – 0.02, p< 0.01 vs. the vehicle group at the same time
point), indicating a successful establishment of the active
immunization model. The AT1-Ab was not detected in the
vehicle group. Additionally, AT1-Abs were of the immuno-
globulin G (IgG) isotype (Fig. 1A), not IgM (OD value,
0.07 – 0.00 vs. 0.08 – 0.00, p > 0.05 vs. the vehicle group, Fig. 1B)
or IgA (OD value, 0.11 – 0.01 vs. 0.10 – 0.01, p > 0.05 vs. the
vehicle group, Fig. 1C). Immunized rats not producing AT1-
Abs were not used in this study.
Sodium dodecylsulfonate–polyacrylate gel electrophoresis
(SDS-PAGE) showed that two strong bands were seen at 55
and 25 KDa, representing the heavy and light chains of total
IgGs from the immunized rats, respectively (Fig. 1D). The IgG
subclass of AT1-Abs in immunized rats was determined to be
mostly IgG2b (OD value, 0.35 – 0.04 vs. 0.08 – 0.01, p< 0.01 vs.
the vehicle group, Fig. 1E), with a minor percentage belonging
to the IgG2a subclass (OD value, 0.10 – 0.01 vs. 0.08 – 0.01,
p < 0.05 vs. the vehicle group, Fig. 1E).
AT1-Abs transport capacity and the pathways involved
By 20 days postconception, the sera of intrauterine fetal rats
of immunized mothers were AT1-Ab-positive, with a P/N
value ([specimen OD- blank control OD]/[negative control
OD - blank control OD]) (19) > 2.1 (OD value, 2.32 – 0.10)
according to the ELISA detection. The vehicle group sera were
AT1-Ab-negative, with a P/N value < 1.5 (OD value,
0.13 – 0.01, p< 0.01 vs. the immunized group, Fig. 2A). As seen
in Figure 2B, strong staining was visualized within the villus
placental trophoblast cell layer and fetal vascular endothe-
lium (short arrow) of the immunized group, indicating the
AT1-Ab presence. The AT1-Ab distribution was very similar
to that of total placental IgGs (long arrow). The staining pat-
tern results suggested general placental IgG crossing in the
vehicle group, but no AT1-Abs were identified.
Figure 2C demonstrated that milk obtained from the neo-
natal gastric contents (7) in the immunized group contained
significantly higher AT1-Ab titers than the vehicle group after
1 week of nursing (OD value, 1.34 – 0.11 vs. 0.19 – 0.03,
p < 0.01). To obtain more evidence that mothers’ milk is an-
other route via which AT1-Abs are passed to newborns, cross-
feeding was initiated. Three pairs of mother rats met the
inclusion criteria for this experiment phase (one pair was ex-
cluded due to refusing breastfeeding). After 7 days, AT1-Abs
were manifested in the sera of the female newborn vehicle rats
breastfed by the immunized mothers (OD value, 2.60 – 0.05 vs.
0.16 – 0.03, p < 0.01 vs. male newborn vehicle rats, Fig. 2D). In
contrast, the AT1-Ab levels in the sera of the immunized fe-
male newborn rats fell sharply after they had been fed by the
vehicle mother rat milk (OD value, 1.04 – 0.12 vs. 2.62 – 0.08,
p < 0.01 vs. male newborn rats in the immunized group). The
experiment was repeated with mother rats exchanging male
infants, with similar results (Supplementary Fig. S1; Supple-
mentary Data are available online at www.liebertonline.com/
ars), confirming the transference of AT1-Abs via mothers’
milk.
Biological activity of AT1-Abs
in the immunized group’s newborns
Elevated titers of AT1-Abs were still present in the sera of
22-day-old (normal weaning age) immunized group rats, but
not in the vehicle group offspring rats (2.22 – 0.10 vs.
0.13 – 0.01, p < 0.01, Fig. 3A). Antibody titers gradually de-
clined and were undetectable after the 7th week.
As shown in Figure 3B, 1lM IgG fractions isolated from
AT1-Ab-positive newborn rats induced significant vasocon-
striction, similar to angiotensin II (AT1 receptor agonist) of the
same concentration (contraction values, 0.44 – 0.05 g and
0.49 – 0.07 g, respectively). Furthermore, the vasoconstrictive
response was markedly blocked (0.05 – 0.02 g, p< 0.01 vs. IgG
from immunized group offspring) by 10 lM losartan (AT1
receptor blocker). The IgG fractions from vehicle newborns
demonstrated no vasoconstrictive effects, even at IgG con-
centrations of 5 lM.
As summarized in Figure 3C and Supplementary Video S1,
within 8 min, a significant increase of intracellular Ca2 + level
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in cultured aortic smooth muscle cells (SMC) was apparent
after stimulation with IgG fractions from the immunized
group newborn rats (1lM). Maximal change of fluorescence
occurred after 1 min ( p < 0.01 vs. vehicle IgGs) and gradually
decreased. Cellular preincubation with losartan (10 lM) for
20 min caused markedly reduced and delayed Ca2 + uptake,
while vehicle IgGs (1lM) had no effect on intracellular Ca2 +
at any time. These in vitro experiments suggested that the
circulating AT1-Abs in offspring might activate the AT1 re-
ceptor in a pathophysiological fashion.
Offspring body weight at age 0 and 3 weeks
Immunized group newborn rats’ birth weights tended to be
slightly decreased compared with the vehicle group, but not
statistically significant ( p = 0.06, 6.21 – 0.09 g vs. 6.46 – 0.09 g,
Fig. 4A). Unexpectedly, the immunized group offspring body
weight values demonstrated much greater variability com-
pared with the vehicle group. Figure 4B and Supplementary
Figure S2 revealed the body weights of both groups of 3-
week-old offspring.
FIG. 1. Production of auto-
antibody against the angio-
tensin II type 1 receptor
(AT1-Abs) titers was gener-
ated in female rats immu-
nized with human second
extracellular loop of AT1 re-
ceptor (AT1R-ECII), and the
immunoglobulin (Ig) class/
subclass was determined.
Female Wistar rats were ac-
tively immunized with
AT1R-ECII. Sera production
of IgG isotype AT1-Ab (A,
IgG-AT1-Ab), immunoglobu-
lin M isotype AT1-Ab (B,
IgM-AT1-Ab), and immuno-
globulin A isotype AT1-Ab
(C, IgA-AT1-Ab) were dy-
namically monitored by en-
zyme-linked immunosorbent
assay (ELISA). Antibody titer
is defined by optical density
(OD) value. n= 10–12.
**p < 0.01 versus the vehicle
group at the same period.
Immu, immunized group fe-
male rats; Vehicle, vehicle
group female rats. (D) Total
sera IgGs of immunized rats
were purified, and evaluated
by sodium dodecylsulfonate–
polyacrylate gel electropho-
resis. (E) The IgG1, IgG2a,
IgG2b, and IgG2c subclasses
of AT1-Ab were determined
by ELISA. n= 10–12. *p< 0.05,
**p < 0.01 versus vehicle.
Immu, immunized group
IgGs; Vehicle, vehicle group
IgGs.
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The presence of insulin resistance in 40-week-old
immunized group offspring given a normal diet
The offspring of AT1-Ab-positive/negative pregnant rats
were fed and raised in typical fashion until they reached 40
weeks of age. No significant difference was observed between
the two groups with regard to fasting plasma glucose (FPG,
5.60 – 0.23 mM vs. 5.01 – 0.21 mM, p> 0.05, Fig. 5A) or blood
pressure (97.8 – 2.2 mmHg vs. 100.9– 2.9 mmHg, p> 0.05, Fig.
5B). However, fasting insulin in the offspring of AT1-Ab-
positive mothers was greatly increased (23.6 – 0.9 lIU/ml vs.
12.9 – 0.6 lIU/ml, p< 0.01, Fig. 5C), and the homeostasis
model assessment for insulin resistance (HOMA-IR) was also
elevated (5.60 – 0.20 vs. 2.30 – 0.16, p< 0.01, Fig. 5D).
Development of MetS in adult offspring of the
immunized group subject to high-sugar diet challenge
Results presented in Figure 5 demonstrated that the off-
spring of AT1-Ab-positive pregnant rats developed IR un-
der normal living conditions. To determine whether an
impaired insulin response in these animals may contribute
to the development of MetS when the animals were fed with
high-sugar food, additional experiments were performed.
A high-sugar diet (20% sucrose) was administered to the
offspring during postnatal weeks 40–48. FPG in the offspring
of AT1-Ab-positive pregnant rats moderately increased at
44 weeks (6.14 – 0.27 mM vs. 5.56 – 0.11 mM, p = 0.067) and
markedly increased at 48 weeks (6.28 – 0.23 mM vs. the ve-
hicle group 5.28 – 0.18 mM, p < 0.01, Fig. 6A). Dyslipide-
mia accompanied the hyperglycemia observed. Compared
with the vehicle group, an increased ratio of visceral fat
weight to body weight (VF/BW, 8.1% – 0.4% vs. 6.0% – 0.5%,
p < 0.01, Fig. 6B), elevated triglycerides (TG, 6.69 – 0.38 mM
vs. 2.57 – 0.31 mM, p < 0.01, Fig. 6C), and decreased high-
density lipoprotein cholesterol (HDL-C, 0.47 – 0.03 mM
vs. 0.29 – 0.03 mM, p < 0.05, Fig. 6D) were observed in the
immunized group offspring, indicative of MetS.
Additionally, hepatic fat accumulation in the rats was deter-
mined. In the immunized group offspring, numerous lipid
droplets of various sizes were observed in the hepatocyte cyto-
plasm. In severe cases, hepatocyte nuclei were peripherally
displaced, similar to adipocyte morphology. Portal region vas-
cular dilatation, congestion, and significant inflammatory cell
infiltration were observed (Fig. 6E). Vehicle offspring manifested
grossly normal lobular architecture. Hepatocytes were arranged
in a radial distribution surrounding the central vein. However,
mild vascular dilatation, congestion, and inflammatory cell in-
filtration were observed in some portal regions (Fig. 6E).
FIG. 2. AT1-Abs could be transferred to offspring rats via the placenta and mother’s milk. (A) AT1-Ab-positive/negative
female rats (n = 3/group) were mated with normal male rats. Twenty days after conception, caesarean sections were per-
formed. Intrauterine infant AT1-Ab sera levels were determined by ELISA. n=12. **p<0.01 versus V-fetus. (B) Immuno-
histochemistry located AT1-Abs (short arrow) and total IgGs (long arrow). The presence of cytoplasmic granules indicated antibody
positivity. Scale bar= 100lm. (C) Female rats in the two groups (n= 7–9) were mated with normal male rats and delivered
naturally. After 1 week of nursing, the AT1-Ab levels in mother’s milk from several newborns’ gastric contents were determined by
ELISA. n=12. **p< 0.01 versus V milk. (D) Mother rats in different groups, but delivering on the same day, were selected for the
cross-feeding experiment. One week later, the AT1-Abs in the subgroups were determined. ##p<0.01 versus V. {p<0.01 versus I. V
(B), vehicle group male newborns; I-V (C), vehicle group female newborns fed by immunized mother rats; I (:), immunized
group male newborns; V-I (6), immunized group female newborn rats fed by vehicle mother. V, vehicle group; I, immunized
group. (To see this illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars).
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Recent clinical and experimental studies have demon-
strated that plasma levels of adiponectin, an adipokine with
strong antidiabetic and cardioprotective properties, is signif-
icantly reduced in obesity and diabetes. To determine whe-
ther the offspring of AT1-Ab-positive pregnant rats may have
altered adiponectin production, serum adiponectin levels
were determined. As summarized in Figure 6F, serum adi-
ponectin levels decreased significantly in the immunized
group offspring compared with the vehicle group
(3818– 612 lg/L vs. 5837 – 678lg/L, p< 0.05, Fig. 6F).
Discussion
In the current study, we emphasize several important
observations, the first of which is that AT1-Abs can be
transferred from mother rats to offspring via the placenta and
FIG. 3. AT1-Ab existed in the early neonatal stage, and provided positive effects on vascular function in vitro. (A)
Attenuation of AT1-Abs in the sera of immunized group offspring. n = 8–12. **p < 0.01 versus V babies. AT1-Ab, angiotensin
AT1 receptor antibodies; V, vehicle group; I, immunized group. (B) The direct effects of angiotensin II (Ang II), IgGs isolated
from the sera of immunized group offspring (Ab) and vehicle group offspring (Vehi) on isolated rat aortic rings were
observed. The blocking effect of losartan (LST) on immunized group IgG-induced vascular effects (LST +Ab) was also
recorded. n = 6. **p< 0.01 versus Vehi; ##p< 0.01 versus Ab +LST. (C) Effects of Ig on intracellular Ca2 + variations (F-F0) in
cultured aortic smooth muscle cells were dynamically detected by confocal microscopy for 8 min. For each group, the left
image displays the basic intracellular Ca2 + level, the middle image displays changes in intracellular Ca2 + 1 min after treatment,
and the right image demonstrates the differential interference contrast microscope images. Scale bar= 30 lm. *p< 0.05,
**p < 0.01 versus Vehi and Ab +LST. F0, the fluorescence intensity at baseline; F, the fluorescence value at each recording time.
(To see this illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars).
FIG. 4. Abnormal body weights of im-
munized group newborn rats. (A) The
mean birth weight of both immunized
and vehicle groups. The number is 47
and 42, respectively. p = 0.06 versus V
newborn. (B) The typical body weight
distribution of 3-week-old neonates born
to the same mother, immunized and ve-
hicle group. V newborn, vehicle group
baby rats; I newborn, immunized group
baby rats.
AT1 RECEPTOR ANTIBODY AND OFFSPRING DEVELOPMENT 737
FIG. 5. Changes in glucose metabolism
and blood pressure were observed in
adult rat offspring. Fasting serum insulin
(Fins, C) and the homeostasis model as-
sessment for insulin resistance (HOMA-
IR, D), but not fasting plasma glucose
(FPG, A) and blood pressure (BP, B), in-
creased in 40-week-old immunized group
offspring fed a normal diet, compared
with the vehicle group offspring. n = 8/
group. **p< 0.01 versus V offspring. V
offspring, offspring rats in vehicle group;
I offspring, offspring rats in immunized
group.
FIG. 6. Glucose and lipid metabolic balance disrupted in adult offspring given high-sugar diet challenge. Fasting
plasma glucose (FPG, A), the ratio of visceral fat/body weight (VF/BW, B), serum triglycerides (TG, C), high-density
lipoprotein cholesterol (HDL-C, D), and adiponectin concentration (F) were detected in offspring rats subject to a high-sugar
diet during postnatal weeks 40–48. (E) Morphologic hepatic changes of adult offspring from both immunized (right images)
and vehicle groups (left images) were determined by classic hematoxylin-eosin staining. Scale bar= 450lm (· 100), 180lm
( · 250). n = 8/group. *p < 0.05, **p< 0.01 versus V offspring at the same period. V offspring, offspring rats in vehicle group; I
offspring, offspring rats in immunized group. (To see this illustration in color the reader is referred to the web version of this
article at www.liebertonline.com/ars).
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milk. Previous studies have demonstrated that IgG passes
through the human placental barrier (yolk sac membrane in
rats) and the neonatal enterocyte membrane (where milk is
absorbed) through specific major histocompatibility complex
class I–related Fc receptor (FcRn) binding. Among four rat
IgG subclass types (IgG1, IgG2a, IgG2b, and IgG2c), IgG2a
and IgG2b exerted greater affinity for FcRn, and crossed both
the placental barrier and the neonatal enterocyte membrane
more easily (8, 27). Our current study demonstrated that AT1-
Abs in the sera of immunized female rats were predominantly
IgG2b, with a very minor portion being IgG2a. These data
provide credible theoretical support for the transference of
AT1-Abs to offspring via the placenta and milk.
The rat yolk sac, similar to the human placenta, engages in
maternal IgG transport by way of the syncytiotrophoblast and
endothelial monolayer of villus, both of which express FcRn
(17). Our current results illustrated that the sera of fetal rats
born to antibody-positive pregnant rats contained high levels
of AT1-Abs before labor onset; the vehicle group fetuses
harbored no AT1-Abs. Such observations are identical to a
recent clinical report (10) and suggest the ability of AT1-Abs
to cross the rat placenta. Thus, since our current study pro-
vided only indirect evidence for antibody transfer, we sought
specific morphological evidence identifying placental cross-
ing of AT1-Ab. First, the immunogen, AT1R-ECII peptide, was
conjugated to horseradish peroxidase (HRP). We located the
target antibody in the yolk sac tissue via immunohistochem-
istry. Similar to general IgGs, AT1-Abs are distributed within
the syncytiotrophoblast cell layer and vascular endothelium
of the rat placenta in the immunized rat group, providing the
first direct evidence for AT1-Abs transference via the placenta.
Maternal milk ingestion is another basic IgG transport
pathway. Milk IgGs are specifically recognized by FcRn and
transported across the newborn rat’s intestinal epithelium
into the circulation. Due to the difficulty associated with col-
lection, we extracted maternal milk from the stomachs of
newborn rats (7). ELISA showed AT1-Ab-positivity in the
immunized group milk, making it potentially possible for
antibodies to be transferred via milk ingestion. However, in-
fant rat’s stomach milk had a variety of confounding factors,
including saliva, gastric juices, blood, and so on; therefore, the
gastric contents might not completely represent pure mothers’
milk composition. We then designed a cross-feeding experi-
ment to confirm the transfer of AT1-Abs through milk (5). Due
to the difficulty involved in distinguishing neonatal rats (the
lack of hair and the tendency of mother rats to eat them when
marked with ink or dye), we first separated the neonatal rats
from both the immunized and vehicle groups by gender in
order to facilitate the distinction among different subgroups.
The exchange of the same sex newborns between two groups
served as an experimental variable, and the un-exchanged
offspring served as a control. AT1-Abs were present in the
sera of the vehicle group neonatal rats cross-suckled by
the immunized group mother rats after 1 week. Conversely,
the AT1-Ab levels in the immunized group offspring mark-
edly decreased after cross-feeding by the vehicle mother rats.
Altogether, the data just provided fully demonstrated AT1-
Ab transferability via milk, further demonstrating the trans-
ference mechanisms of AT1-Ab from mother to young.
A second important finding of the current study is that
AT1-Abs in newborn rats remain biologically active and exert
agonist-like effects through AT1 receptor activation. As seen
in patients harboring autoantibodies (26, 33), the exogenous
administration of AT1-Ab-positive sera IgGs obtained from
baby rats induced significant thoracic aortic ring contractions
and enhanced intracellular Ca2 + in cultured aortic SMC
in vitro, similar to angiotensin II. These results suggested that
early-life exposure to AT1-Abs (including the intrauterine and
early postnatal stage) might be dangerous for offspring rats.
Thus, excessive activation of the AT1 receptor might result in
multiple pathophysiological effects, such as destroying vas-
cular endothelial cells (35), inducing inflammation (4), pro-
moting the secretion of aldosterone, and inhibiting the
metabolic effects of insulin (24).
Third and the most clinically significant finding of the
present study is that the AT1-Ab-positive offspring harbors
several pathological alterations. First, birth weight is an im-
portant indicator reflecting fetal health. Abnormal birth
weight shares a close relationship with multiple adult-onset
diseases according to epidemiological data (2, 6). A non-
statistically significant downward trend was observed in
AT1-Ab-positive pregnant rat fetal birth weights ( p= 0.06).
Interestingly, there was distinctly greater body weight vari-
ability in the immunized group newborns compared with the
vehicle group during weaning. Second, on reaching 40 weeks
old (equivalent to human middle-aged life), having been fed a
normal diet, AT1-Ab-positive pregnant rats’ offspring ex-
hibited normal FPG and blood pressure, but elevated serum
insulin levels and increased HOMA-IR, indicating IR, while
the vehicle group’s metabolic parameters remained normal.
Moreover, IR is a precursor to MetS, which may be due to
genetic changes and/or adverse environmental factors (13,
18). The present study’s data suggest that offspring born to
AT1-Ab-positive mothers may have increased susceptibility
to metabolic derangement by middle age. Finally, the off-
spring of AT1-Ab-positive pregnant rats were more sensitive
to a high-sugar diet challenge. By 48 weeks postnatally, off-
spring of AT1-Ab-positive mothers demonstrated impaired
fasting glucose, impaired glucose tolerance (Supplementary
Fig. S3), increased visceral fat deposits, high TG, and low
HDL-C, with normotension (data not shown), meeting the
criteria for MetS criteria (1). In comparison, rats of the vehicle
mothers subjected to the same conditions were of a nearly
normal metabolic profile.
Direct/indirect impaired effects of AT1-Abs on the devel-
opment of the placenta may explain the lower birth weight of
rat offspring in the present study (4, 12, 32). AT1-Abs might
contribute to uteroplacental ischemia/hypoxia, which is fol-
lowed by increased fetoplacental vascular resistance and fi-
nally resulting in poor nutrient supply to the fetus (23). Then,
for survival, the fetus would adapt its physiological devel-
opment, including downregulating its growth, resetting the
endocrine systems and metabolic homeostasis (28). Although
beneficial for survival in utero, the fetus would be maladaptive
and sensitive to metabolic and CVD when exposed to mis-
matched postnatal environments, such as catch-up growth, an
atherogenic diet, and other risk factors.
Recently, both clinical and animal research suggest that the
epigenetic modulation of transcription is partially responsible
for the links between prenatal and postnatal influences and an
increased risk of adult-onset diseases. Nutrient restriction in
early life may directly induce epigenetic changes in growth
and regulatory-related genes, which will cause permanent
structural and functional alterations of important organs,
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such as the liver, pancreas, kidney, and the hypothalamic-
pituitary-adrenal axis. Additionally, the phenotypic effects of
epigenetic modifications during development may not man-
ifest until later in life, especially when responding to envi-
ronmental challenges (9, 14). Therefore, in our study, we
speculated that the large degree of variation in offspring birth
weights may be due to interactions between variations in the
environment, adaptive epigenetics, and individual behavior.
Furthermore, the mechanisms underlying the close associa-
tion between early-life exposure to AT1-Abs and increased
susceptibility to adult-onset MetS may be destroyed tissues
and organs via various pathways (such as restricting nutri-
tion, activating inflammatory cytokines) and/or epigenetic
modulation of key genes. In addition, the oxidative stress and
inflammation-related signal pathways (mitogen-activated
protein kinase pathway, nuclear facor-jB signaling pathway,
and so on) may play critical roles in the process (3, 4, 11, 25).
However, the precise underlying mechanisms responsible are
the subject of ongoing study.
In summary, we have demonstrated that AT1-Abs can be
transferred from mother rats to their offspring and increase
the offspring’s risk of developing IR and MetS in middle and
late life. These results strongly suggest that the AT1-Ab-pos-
itivity of mothers during pregnancy is a previously unrecog-
nized ‘‘silent’’ risk factor for the development of MetS in their
offspring. Since MetS has become one of the major public-
health challenges worldwide, therapeutic interventions that
block the adverse effects of AT1-Abs during pregnancy, or
preventive actions (e.g., a low-sugar, low-calorie diet) taken
by the descendants of AT1-Ab-positive pregnant women,
may be novel strategies in the battle against MetS and its
cardiovascular complications.
Study limitations
We used an active immunization rat model in the present
study. As a classic method for autoimmune disease research,
active immunization with a given autoantigen is easy to op-
erate and widely applied. However, the levels of antibodies
produced in the experimental animals are difficult to control,
because the process depends on not only the dose of the an-
tigen, but also the individual’s immune status. The AT1-Ab
levels in the mother rats in our study are a little higher than
those in pre-eclamptic patients (36). We will use an alternative
rat model that will be passively immunized with AT1-Ab in
future studies. Furthermore, with a new model, various po-
tential risk factors for MetS development, such as insulin,
leptin, adiponectin, aldosterone, tumor necrosis factor-a, and
glucocorticoid, should be dynamically monitored throughout
the process. Another phenomenon which needs further ex-
ploration is that there is no hypertension in the offspring. It
may be due to the complex regulation of blood pressure
in vivo (such as depressor reflex) or our failure to capture the
transient increase in blood pressure.
Materials and Methods
Animals
AT1-Ab-negative female (for establishing an active immu-
nization model) and male (for mating) Wistar rats (8 weeks
old) were used. All research procedures complied with the
‘‘Guiding Principles in the Use and Care of Animals’’ pub-
lished by the National Institutes of Health (NIH Publication
No. 85-23, Revised 1996) and were approved by the Institu-
tional Animal Care and Use Committee of the Shanxi Medical
University. The normal rat diet contained 280 g farina tritici,
125 g wheat bran, 375 g corn flour, 65 g soybean meal, 25 g fish
meal, 2.5 g calcium lactate, 1.25 g probiotics, and 10 g salt per
kilogram. The high-sugar diet was supplemented with 20%
sucrose. The rat food was provided by the Experimental
Animal Center of the Shanxi Medical University, China
(production license No. SCXK[Jin] 2009-0001).
Immunization protocol
The peptide corresponding to the sequence of human
AT1R-ECII was synthesized as previously reported (35).
Twenty-four female Wistar rats were randomly assigned to
two groups. The immunized group rats were actively im-
munized with synthetic AT1R-ECII peptide every 2 weeks as
per the previous protocol (19). After 8 weeks, immunized fe-
male rats were mated with normal male rats (nonimmunized).
During pregnancy and nursing periods, the female rats re-
ceived monthly immunization. Thus, the mother rat models
that possessed a relatively stable level of AT1-Ab would be
established (35). Caudal vein blood was drawn before each
immunization, and serum was collected to monitor antibody
generation using the ELISA method as previously reported.
The level of AT1-Ab was expressed as OD value, which is also
called absorbance (A). Ak = lg(I0/I), where I is the transmitted
light intensity at a specified wavelength l and I0 is the incident
light intensity. The absorbance is proportional to the con-
centration of the absorbing species in the sample and usually
used to reflect the relative concentration of a sample. Acting as
a reference, a control sample is essential. The positivity of the
sample to AT1-Ab was also defined as P/N ‡ 2.1, while the
negativity was defined as P/N £ 1.5 (35). The vehicle group
rats were treated with a mixture of Freund’s complete/in-
complete adjuvant (without antigen) and saline in an identical
manner.
Preparation of IgG and the subclasses identification
Total IgGs from the sera of immunized female rats con-
taining maximal AT1-Abs were extracted by Mab Trap Kit
(Amersham). Extraction purity was assessed by conventional
SDS-PAGE. The IgGs from the vehicle group sera were ob-
tained by an identical protocol. The purified IgGs subclasses
were identified by ELISA methods. The dilution ratios of
biotinylated goat anti-rat IgG1, 2a, 2b, and 2c antibodies (AbD
Serotec) were 1:6000, 1:6000, 1:8000, and 1:8000, respectively.
HRP-AT1R-ECII probe preparation
AT1R-ECII antigen peptides were conjugated with HRP
utilizing a Glue-B-type-activated HRP conjugation kit (Galaxy
Bio). Briefly, the AT1R-ECII antigen peptide was diluted in
double-distilled water to a concentration of 1 mg/ml. One
hundred microliters of antigen solutions were added to the
activated HRP (the HRP/antigen molecular molar ratio was
maintained at around 30:1). The reaction body was regulated
at pH 9.5 by a starting agent and incubated overnight at 4C
or at 37C for 2 h. Then, 10 ll of stop solution was added
and mixed for 15 min to cease the reaction. The mixtures
were dialyzed for 48 h by dialysis bags with MW10000
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interception. The water was changed six times to completely
remove free AT1R-ECII peptides. Antigen molecules-HRP
conjugates in liquid state were adjusted to pH 7.0 by 1 M
phosphate buffer. This HRP-AT1R-ECII probe could specially
recognize AT1-Abs, and was stored at - 40C until needed.
Immunohistochemistry
Location of AT1-Abs. Twenty-day pregnant (in labor)
rats were intraperitoneally anesthetized with 10% chloral
hydrate (3 ml/kg), and caesarean operations commenced. The
placentas were removed and fully perfused with phosphate-
buffered saline (PBS, pH 7.2) via the umbilical vein. The tis-
sues were then fixed in 4% paraformaldehyde solution, and
embedded in paraffin. Sections were cut at 8 lm and mounted
onto glass slides. After dewaxing and hydrating, 3% H2O2
was added, and the samples were incubated for 10 min at
room temperature. After three washings with PBS (5 min per
time), the slides were subjected to high-pressure antigen re-
trieval (0.01 M sodium citrate buffer, pH 6.0, 270C, 10 min),
followed by another three PBS washings. The AT1R-ECII
peptides conjugated to HRP (diluted in 5% PBS-Milk-
Tween(PMT) solution [5% bovine serum albumin or 5%
skimmed milk in PBS with 0.1% Tween-20], 1:100) were ad-
ded and incubated overnight at 4C. After another PBS
washing, the slides were subjected to a diaminobenzidine
(DAB) staining reagent.
Distribution of general IgGs. Placental samples were
treated with rabbit anti-rat IgG antibody (diluted 1:200 in
PMT; Bioss. Inc.) and incubated overnight at 4C. Then,
biotinylated goat anti-rabbit IgG secondary antibody was
added and incubated at 37C for 20 min. The process was
repeated with HRP-labeled avidin under the same condi-
tions. A PBS washing was performed following every step,
concluding with a DAB staining reagent. The appearance of
intracytoplasmic brown granules indicated the target anti-
body presence.
Milk collection and cross-feeding design
Mother rats’ milk was collected from the stomachs of
newborns after nursing as per a classically utilized technique
(7). The AT1-Ab content of the milk was determined by ELISA
via the same process as serum antibody detection.
In the cross-feeding experiment protocol, the immunized
group and vehicle group mother rats that delivered on the
same day were paired. Their newborns were separated by
gender. In one pair of mother rats, male newborns were fed by
their mother, and female newborns were exchanged for cross-
feeding by the opposite group’s mother. There were four
subgroups: the vehicle group male newborn rats; the immu-
nized group female newborn rats fed by the vehicle mother
rats; the immunized group male newborn rats; and the vehicle
group female newborn rats fed by the immunized mother
rats. After 7 days of feeding, the serum AT1-Ab levels were
compared among the subgroups. In another pair of mother
rats, the female newborns were fed by their mother, and the
male newborns were exchanged for cross-feeding.
Preparation of thoracic aorta rings
To determine whether the AT1-Ab present in offspring
sera was biologically active, total AT1-Ab-positive/negative
IgGs in the offspring sera were purified by the previ-
ous method. The effects of the IgGs on thoracic aorta and
intracellular-free Ca2 + in SMC were observed in vitro. The
vasoconstriction of thoracic aorta rings was performed as
previously described (33).
Determination of intracellular-free Ca2+
Male Wistar rats were anesthetized with 10% chloral hy-
drate (3 ml/kg, intraperitoneal injection). The thoracic aortic
SMC were isolated and primarily cultured. Intracellular-free
Ca2 + concentration in SMC was monitored utilizing Fluo-3/
AM, a common fluorescent Ca2 + indicator, in the dark (34).
The changes in intracellular Ca2 + were defined as the differ-
ence between the fluorescence intensity at each recording time
and the baseline fluorescence value. Ten cells in each group
were randomly selected for image analysis.
Metabolism test
After a 12-h overnight fast, the levels of blood glucose, in-
sulin, TG, and HDL-C were analyzed. Plasma glucose levels
were determined by an automated glucose oxidase method
(One Touch Ultra; LifeScan). Serum insulin was detected by a
commercial double-antibody solid-phase radioimmunoassay
(Coat-A-Count; DPC). Serum TG and HDL-C were assessed
with an autoanalyzer (VetAce). HOMA-IR was calculated as
(FPG [mM]· fasting insulin [lIU/ml]/22.5) (16). Both sides of
the perirenal and epididymal fat weights were recorded as the
visceral fat weight, and VF/BW was calculated. In addition,
serum adiponectin was detected by an ELISA kit (R&D).
Blood pressure was determined by tail-cuff plethysmography.
Statistical analysis
All data were described as mean– standard error of mean.
Statistical analysis was performed with the SPSS 15.0 pro-
gram. The t-test was used to compare two independent
sample means, and one-way ANOVA was utilized for com-
paring means of more than two samples. The intracellular
Ca2 + variations in different groups were compared by re-
peated-measures ANOVA. All pregnant rats and their off-
spring were randomly assigned to different experiments.
A p-value < 0.05 was considered statistically significant.
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AT1-Ab¼ autoantibody against the angiotensin II
type 1 receptor
AT1R-ECII¼ second extracellular loop of the AT1 receptor
AUC¼ area under the glucose curve
CVD¼ cardiovascular diseases
DAB¼diaminobenzidine
ELISA¼ enzyme-linked immunosorbent assay
FOAD¼ fetal origin of adult disease
FPG¼ fasting plasma glucose
HDL-C¼high-density lipoprotein cholesterol




IUGR¼ intrauterine growth restriction
MetS¼metabolic syndrome
OD¼ optical density





SMC¼ smooth muscle cells
VF/BW¼ ratio of visceral fat weight to body weight
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